Hamburg, Germany - 03 March 2017:
Evotec AG and Business France today released their short film about Evotec's research site in Toulouse, France, under the headline: "Evotec found Business in France - Great story, short film".
Business France supports the international development of the French economy with the goal to promote France's attractiveness. The agency's press department regularly produces video testimonials of international companies that have chosen France as an investment site. For that reason, Evotec was chosen to engage in this film following its acquisition of Evotec (France) SAS, which is located in Toulouse, in April 2015. Evotec was pleased to support Business France to produce this great film about its French research site.
Please click here and enjoy.
About Business France Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France.It promotes France's companies, business image and nationwide attractiveness as an investment location, and also runs the VIE international internship program.Founded on January 1, 2015 through a merger between UBIFRANCE and the Invest in France Agency, Business France has 1,500 personnel, both in France and in 70 countries throughout the world, who work with a network of public- and private-sector partners.
For further information, please visitwww.businessfrance.fr
Evotec AG published this content on 03 March 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 03 March 2017 10:33:14 UTC.
Original documenthttps://www.evotec.com/archive/en/Press-releases/2017/Great-story-Short-film/2940/1
Public permalinkhttp://www.publicnow.com/view/DEF4673462F912BC3E078211ED49A105F4F3CBAA
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women's health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
EVOTEC SE 
